Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is rare, affecting more girls than boys, and peaks at ages 9-12.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

PRP treatment increased hair density, especially in men and younger patients with AGA.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

PRP is an effective and safe treatment for hair loss.

Parry–Romberg Syndrome can involve the brain even without obvious symptoms, and a new diagnostic framework is suggested for early detection.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A girl had rickets due to a gene mutation affecting vitamin D response.

New medications could improve treatment for severe alopecia areata in Australia.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Polarity Analysis with Calcarea Carbonica may effectively treat alopecia areata with fewer side effects.

Black and Hispanic women are more likely to have alopecia areata than white women.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

More frequent PRP sessions with shorter intervals improve hair loss treatment.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Androgen receptors help prostate cancer cells grow and resist drugs.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.